Pharmaceutical Science Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login
International Pharmacy Acta
  • Home
  • Journal Info
    • About the Journal
    • Publisher
    • Aim and Scope
    • Ownership & Management
    • Indexing and Abstracting
    • Editorial Team
    • Privacy Statement
    • Journal History
  • Issues
    • Current
    • Archives
  • For Authors
    • Author Guidelines
    • Types of articles
    • Templates
    • Publication Fees
    • Peer Review Process
  • For Reviewers
    • Reviewers' Guidelines
    • Responcibility for Reviewres
  • Publication Ethics
    • Publication Ethics and Malpractice Statement
    • Code of Publishing Ethics
  • Policies and Process
    • Allegations of Misconduct
    • Article Processing Charge (APC)
    • Advertisement and Marketing
    • Archiving
    • Article Withdrawal & Retraction Policy
    • Conflict of Interest
    • Copyright Notice
    • Complaints Policy
    • Editorial Policies
    • Open Access Policy
    • Peer-Review Policy
    • Post- Publication Discussions and Corrections Policy
    • Principles of Transparency
    • Publication Policy
    • Repository
    • Using Artificial Intelligence (AI) Plicies
  • New Submission
  • FAQ
  • Contact us
Advanced Search
  1. Home
  2. Archives
  3. Vol. 1 No. 1 (2018): Pharmacy Updates 2018 (Congress Proceeding)
  4. Supplementary Issues: Reviews of books, journal, congress, other media Special issues, and Scientific news

Vol. 1 No. 1 (2018)

March 2018

Nephroprotective effect of Gallic acid against mercuric chloride (HgCl2) induced damage in rats

  • Hadi Kalantar
  • Mojtaba Kalantar
  • Heibatullah Kalantari
  • Mehdi Goudarzi
  • Mohsen Rashidi

International Pharmacy Acta, Vol. 1 No. 1 (2018), 4 March 2018 , Page 49-50
https://doi.org/10.22037/ipa.v1i1.20117 Published: 2018-03-04

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Introduction: Mercury has hematotoxic, hepatotoxic, neurotoxic, nephrotoxic and genotoxic effects. Tissue damage induced by mercuric chloride (HgCl2) is associated with the promotion of oxidative stress. In this study, Gallic acid (GA), as potent antioxidant compound, was examined against mercuric chloride (HgCl2)-induced kidney injury in Wistar rats.

Methods and Results: In this experimental study, animals were divided into five groups (n=7). Groups 1 and 2 respectively received normal saline (2 ml/kg, orally.) and HgCl2 (0.4 mg/kg, orally) for 28 consecutive days. Group 3 only received GA (200 mg/kg, orally) for 28 consecutive days. Groups 4 and 5 received orally GA at doses of 50 and 200 mg/kg, respectively, one hour after administration of HgCl2 for 28 consecutive days. Then On the 29th day, the rats were sacrificed, and blood samples were collected to determine biochemical parameters such as serum creatinine (Cr) and blood urea nitrogen (BUN) levels. For oxidative stress evaluation, malondialdehyde (MDA) and reduced glutathione (GSH) levels and also catalase (CAT), glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity were evaluated in left kidney tissue. The right kidney was used for histological examination. The results obtained from our study showed a significant increase in the levels of MDA, Cr and BUN, and decrease of GSH, CAT and SOD after ingestion of HgCl2 (p<0.05). Pre-treatment with GA showed diminished in the levels of MDA, Cr and BUN and enhanced of GSH, CAT, GPx and SOD activity (p<0.05). Additionally the nephroprotective effect of the GA was established by the histological evaluation of the kidneys.

Conclusions: Our results indicate that GA has protective effect against HgCl2-induced renal damage probably by scavenging free radicals, reducing the oxidative stress, and increasing the antioxidant defense mechanism.

Keywords:
  • Nephrotoxicity, Mercuric chloride, Gallic acid, Rat
  • PDF

How to Cite

Kalantar, H., Kalantar, M., Kalantari, H., Goudarzi, M., & Rashidi, M. (2018). Nephroprotective effect of Gallic acid against mercuric chloride (HgCl2) induced damage in rats. International Pharmacy Acta, 1(1), 49–50. https://doi.org/10.22037/ipa.v1i1.20117
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 495 times
  • PDF Downloaded: 254 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors
  • For Librarians

Make a Submission

Make a Submission
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License.

 

                                                  Online ISSN: 2645-3266

                                                  Print ISSN: 2645-3258                                                 

Powered by OJSPlus